Form 8-K - Current report:
SEC Accession No. 0001104659-21-069626
Filing Date
2021-05-20
Accepted
2021-05-20 09:00:59
Documents
4
Period of Report
2021-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2117015d1_8k.htm 8-K 25355
2 EXHIBIT 10.1 tm2117015d1_ex10-1.htm EX-10.1 38138
3 EXHIBIT 99.1 tm2117015d1_ex99-1.htm EX-99.1 11886
4 GRAPHIC tm2117015d1_ex10-1img001.jpg GRAPHIC 8142
  Complete submission text file 0001104659-21-069626.txt   88277
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21942467
SIC: 2834 Pharmaceutical Preparations